São Paulo Study Identifies 18 Blood-Cell Genes Tied to Depression in 3,072 Samples
Updated
Updated · PsyPost · Jun 12
São Paulo Study Identifies 18 Blood-Cell Genes Tied to Depression in 3,072 Samples
3 articles · Updated · PsyPost · Jun 12
Summary
18 synapse-related genes in white blood cells consistently separated people with major depressive disorder from healthy controls in a University of São Paulo analysis of 3,072 public blood samples.
The team found 1,383 altered genes in patients’ immune cells, including 73 usually linked to synapses, suggesting depression’s molecular signature extends beyond the brain into inflammatory pathways.
Seven of those synapse-related genes were also altered in mood-related brain regions, including the anterior cingulate and orbitofrontal cortex, reinforcing an immune-nervous system overlap.
Disease-network mapping tied the shared genes to bipolar disorder, anxiety, hypertension, arterial disease and psoriasis, offering a possible explanation for depression’s frequent physical comorbidities.
The authors called the work exploratory because it reanalyzed existing, single-time-point datasets; they said lab validation and long-term patient tracking are still needed before blood-based diagnostic panels or treatments emerge.
Is a simple blood test about to make the diagnosis of depression an exact science?
Could treating inflammation be the key to finally solving treatment-resistant depression?
If depression is a disease of the whole body, should we rethink its entire classification?
18 Blood Genes Linked to Major Depressive Disorder: A Breakthrough in Diagnosis and Personalized Care
Overview
A landmark study from the University of São Paulo has identified 18 specific genes in blood cells that are strongly linked to major depressive disorder, marking a major shift from a brain-only view of depression to understanding it as a systemic disease. By analyzing over 3,000 blood samples, researchers found these genes are also involved in inflammation and vascular issues common in depression. This discovery opens the door to new diagnostic tools and personalized treatments, such as using blood-based biomarkers and anti-inflammatory therapies, offering hope for more precise and effective care for people with depression.